A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma

by Daniele Lavacchi, Stefania Nobili, Marco Brugia, Agnese Paderi, Sara Fancelli, Enrico Caliman, Federica Vergoni, Enrico Mini
Published 2018-10-01

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives

by Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-03-01

Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience

by Daniele Lavacchi, Giandomenico Roviello, Elisa Giommoni, Lorenzo Dreoni, Silvia Derio, Marco Brugia, Amedeo Amedei, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-07-01

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer

by Ilenia Bartolini, Maria Novella Ringressi, Filippo Melli, Matteo Risaliti, Marco Brugia, Enrico Mini, Giacomo Batignani, Paolo Bechi, Luca Boni, Antonio Taddei
Published 2018-01-01

Results of the observational prospective RealFLOT study

by Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
Published 2021-10-01